My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Retrovirology. 2004 May 12;1:8.

    HIV CTL escape: at what cost?

    Smith SM.

    Saint Michael's Medical Center and The New Jersey Medical School, Newark, New Jersey 07102, USA. ssmith1824@aol.com

    Recent data have established the HIV-1 and SIV escape CTL through epitope mutation. However, three novel studies prove that such escape comes at a "cost" to overall viral fitness. Understanding how HIV-1/SIV escape CTL and the impact of the escape mutations has tremendous importance in developing CTL based vaccines. Further, a CTL based HIV-1 vaccine is likely to have long-term protective effect against disease only if the escape virus is significantly weakened compared with wild type.

    PMID: 15169568 [PubMed - indexed for MEDLINE]

    PMCID: PMC419725

    Supplemental Content

    Click here to read Click here to read Click here to read
    Write to the Help Desk